Signal-Based Lead Generation
Surface qualified B2B leads across medtech, pharma, health IT, medical devices, and diagnostics. Turn market signals -- regulatory, clinical, financial, and competitive -- into pipeline you can close.
Start Free TrialThe Problem
B2B sales and business development teams in the healthcare and life sciences space waste countless hours hunting for qualified leads. Traditional lead generation relies on job title keyword searches, company size filters, and static industry lists. It misses the signal that matters most: intent.
A company that just received FDA clearance needs manufacturing partners, distribution channels, regulatory consultants, and clinical testing services. A biotech that closed a Series B is staffing up and buying lab equipment. A diagnostics firm that secured an IVDR certificate needs compliant packaging and supply chain support. An academic lab that won an NIH grant is about to procure reagents, instruments, and software licenses.
These market events are purchase signals. Most sales teams never see them. We connect the dots between public signals and buying intent, so your team talks to the right companies at the right moment.
Our Approach
Market signals across six categories mapped to purchase intent
Detect Market Signals
Monitor global public sources in real time for regulatory filings, clinical trials, patent grants, funding rounds, partnership announcements, and grant awards that signal market activity.
Score by Intent
Each signal is scored for purchase intent. A first 510(k) submission scores higher than a routine renewal. A Series A biotech scores higher than an established public company. A new NIH grant signals imminent procurement.
Deliver Qualified Leads
Enriched company profiles with decision-maker contacts, intent score, signal history, market segment, and suggested outreach timing -- ready for your CRM.
Signal Categories
Six signal categories mapped to specific sales and partnership opportunities
Regulatory Activity
FDA 510(k) clearances, PMA approvals, De Novo grants, IVDR certificates, MDR certifications, NMPA registrations. Each filing signals a company that is commercializing and needs services, distribution, and supply chain partners.
Funding & Grants
Series A through IPO, SBIR/STTR awards, NIH R01/R44 grants, Horizon Europe funding, and public market disclosures. Funded companies are actively spending on equipment, headcount, and external services.
Clinical Trials
New trial starts, phase transitions, results postings, and study completions. A trial nearing completion needs manufacturing scale-up, while a new start needs CRO partners, reagents, and site management.
Patent & IP Activity
Patent filings, grants, and licensing announcements across USPTO, EPO, WIPO, and national offices. Active IP portfolios signal companies investing in R&D or preparing to bring new technology to market.
Partnership & Licensing
Distribution agreements, co-development deals, licensing transactions, and strategic partnerships. Companies actively seeking partners are high-intent targets for complementary offerings.
Competitive Intelligence
Product launches, market expansion announcements, leadership changes, workforce growth, and facility investments. These signals reveal companies in growth mode that need partners to scale.
What You Get
Every lead includes the context your sales team needs to close deals faster
Enriched Company Profiles
Company size, location, industry segment, regulatory history, patent portfolio, funding stage, grant history, and key personnel across all target roles.
Contact Discovery
Decision-maker identification with roles, titles, and verified contact information for procurement, R&D, regulatory affairs, business development, and executive teams.
Intent Scoring
Every lead receives an intent score based on signal recency, signal type, company growth stage, market segment, and historical conversion data for your specific offering.
How We Compare
How It Works
From raw market signals to qualified pipeline in minutes
Continuous Signal Collection
Our crawlers poll global public sources 24/7 -- regulatory agencies, clinical trial registries, patent offices, funding databases, grant portals, and news feeds. New signals are detected within minutes of publication.
Classification & Intent Scoring
Each signal is classified into one of six categories and 18+ signal types. An AI-driven intent score is calculated based on signal recency, market impact, company growth stage, and historic conversion patterns for your industry.
Enrichment & Profiling
Signals are enriched with company profiles, decision-maker contacts, industry segment, regulatory history, patent landscape, and funding context. Raw public data becomes structured, CRM-ready intelligence.
Lead Delivery & CRM Sync
Qualified leads land in your CRM with full enrichment, intent score, and suggested outreach timing. Configure automated alerts via email, Slack, or webhook -- trigger sequences the moment a lead crosses your threshold.
Fill Your Pipeline with Qualified B2B Leads
See how signal intelligence can transform your sales and business development process
See Plans & Pricing